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β-cell neogenesis triggers the generation of new β-cells
fromprecursorcells.Neogenesisfromductepitheliumisthe
most currently described and the best documented process
of differentiation of precursor cells into β-cells. It is con-
tributes not only to β-cell mass expansion during fetal and
nonatal life but it is also involved in the maintenance of the
β-cell mass in adults. It is also required for the increase in
β-cellmassinsituationsofincreaseinsulindemand(obesity,
pregnancy). A large number of factors controlling the dif-
ferentiationofβ-cellshasbeenidentiﬁed.Theyareclassiﬁed
intothefollowingmaincategories:growthfactors,cytokine
and inﬂamatory factors, and hormones such as PTHrP and
GLP-1. The fact that intestinal incretin hormone GLP-1
exerts a major trophic role on pancreatic β-cells provides
insights into the possibility to pharmacologically stimulate
β-cell neogenesis. This could have important implications
for the of treatment of type 1 and type 2 diabetes. Transdif-
ferentiation,thatis,thedifferentiationofalreadydifferenti-
atedcellsintoβ-cells,remainscontroversial.However,more
and more studies support this concept. The cells, which can
potentially “transdifferentiate” into β-cells, can belong to
thepancreas(acinarcells)andevenislets,ororiginatefrom
extra-pancreatic tissues such as the liver. Neogenesis from
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intra-islet precursors also have been proposed and subpop-
ulations of cell precursors inside islets have been described
bysomeauthors.Nestinpositivecells,whichhavebeencon-
sidered as the main candidates, appear rather as progeni-
torsofendothelialcellsratherthanβ-cellsandcontributeto
angiogenesis rather than neogenesis. To take advantage of
thedifferentdifferentiationprocessesmaybeadirectionfor
futurecellulartherapies.Ultimately,abetterunderstanding
of the molecular mechanisms involved in β-cell neogenesis
will allow us to use any type of differentiated and/or undif-
ferentiated cells as a source of potential cell precursors.
Keywords Ductal Cell Precursors; GLP-1; Intra-Islet Precursors;
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β-cell neogenesis is the mechanism that triggers the gener-
ation of new β-cells from precursor cells. Although this deﬁ-
nition is largely accepted, the origin and the nature of the cell
precursors are controversial. For a long time, β-cell neogenesis
was considered as a process restricted to the mechanism allow-
ing morphological and functional changes of ductal epithelial
undifferentiated precursors into β-cell [1, 2]. However, recent
data and new concepts suggest that β-cell precursors could not
be located only within pancreatic ducts [3, 4].
Taken into account the most recent ﬁndings and hypotheses,
new β-cells could potentially originate from:
1. Ductal cells by ductal neogenesis.
2. Already differentiated pancreatic cell (i.e., exocrine, acinar
or ductal) or extra-pancreatic cells through a mechanism so
called “transdifferentiation.”
3. An islet precursor cell by intra-islet neogenesis.
Figure 1 summarizes these different possibilities.
In this review we will focus on the mechanism and on the
differentpotentialprecursorsinvolvedinβ-cellneogenesis.We
will also discuss the extent to which a better understanding
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FIGURE 1
Different potential precursors of endocrine β-cells. (A) Ductal precursors are budding from the duct ´ epith´ elium and express the
differentiation maker Glut2. (B) Exocrine cells (amylase in gray) “transdifferentiate” into mature β-cells (insulin in dark gray)
(C) Nestin, a putative intra-islet precursor of insulin-secreting cells (see text for the controversy).
of the mechanisms of β-cell neogenesis could help us in the
possible outcomes for future treatments of diabetes based upon
cell therapy.
NEOGENESIS FROM DUCT EPITHELIUM
Neogenesis from duct epithelium is the most currently de-
scribed and the best documented process by which progenitor
cells can differentiate into endocrine cells.
General Mechanism
Fetus
During fetal life [5], and in the neonatal period [6], intense
β-cell differentiation is the major contributor to β-cell mass
expansion. Two mechanisms are proposed. The ﬁrst one in-
volves the emergence of cells budding from the duct epithe-
lium, and expressing islet hormones, especially insulin [2, 7].
These duct cells able to differentiate into β-cells are called
“precursor cells.” According to a second mechanism, that has
been described only during the fetal life, the source of β-cells
comes from a pool of proliferating cells expressing cytokeratin
(CK) and located near the ductal tree [8]. Although it is difﬁ-
culttoassesswhatistherespectivecontributionofeachofthese
mechanisms in the expansion of β-cell during the fetal stage, it
is admitted that the ﬁrst mechanism is the most current.
Adult
It is now well documented that neogenesis from ducts is in-
volved in the maintenance of the β-cell mass and contributes to
its expansion in situations of increased insulin demand in adult
mammals including humans (reviewed in 9). Besides evident
limitationsintheuseofhumantissuesamples,theregulationof
β-celldifferentiationintheadultstageisnowbetterunderstood,
thanks to the use of animal models of pancreatic regeneration
and adaptation which stressed that β-cell differentiation from
ductal cells can be strongly reactivated. Most importantly, us-
ing speciﬁc models it is possible to recapitulate in the adult
situation, sequences found to occur during the development of
the endocrine pancreas i.e., a wave of ductal proliferation fol-
lowedbyasubsequentdifferentiationofhyperplasticductcells.
The main models are: transgenic mouse over-expressing INFγ
[10], TGFα and gastrin over-expression [11], IL-6 or TNFα
over-expression [12, 13], partial pancreatectomy [14], cello-
phane wrapping [15], main duct ligation [16, 17], and chronic
glucose infusion in adult rats [18–20], which is a model of pan-
creatic adaptation without initial injury of the pancreas. Using
the latest model, it was shown that 24 h of glucose infusion
were enough to double the β-cell mass only by a stimulation of
the neogenic process, β-cell proliferation being of minor im-
portance. It was also demonstrated that hyperinsulinemia and
hyperglycemiaaloneorincombinationareabletodramaticallyPANCREATIC β-CELL 113
activateneogenesisandthenincreasetheβ-cellmass,probably
through speciﬁc ways [20].
Although the different situations of pancreas remodeling
greatly contributed to the understanding of how β-cells dif-
ferentiateintheadultsituation,thequestionregardingthepres-
ence and the location of true pancreatic stem cells in the adult
remainsunansweredor,atleast,largelycontroversial.Forsome
authors there is a pool of resting precursor cells inside ducts,
which has the ability to differentiate into β-cell upon a speciﬁc
stimulus [1, 3]. For other authors, all the ductal cells are poten-
tially precursors and are able to differentiate into β-cells [21,
22].Thesecellsaremaintainedinaquiescentstatusbypresence
ofTGFβ,butproliferationanddifferentiationofthesecellscan
be reactivated upon the action of speciﬁc regulating factors as
described in Figure 2 [23]. Interesting recent observations by
Noguchi et al. [24] ascribe a particular role to the islet master
gene PDX-1 in β-cell neogenesis from ductal cells. Indeed, the
authors showed that PDX-1 protein possesses a protein trans-
duction sequence in its structure, which allows it to permeate
cells. They also showed that transduced PDX-1 into culture of
pancreatic ducts triggered insulin gene expression. This sug-
gests that ductal PDX-1 expression can have paracrine effects
on (potentially progenitor?) neighboring cells within the pan-
creatic duct and then may induce the ﬁrst steps of β-cell differ-
entiation.Thisisanattractivehypothesis,whichneedshowever,
further conﬁrmation.
Currentlythereisnouniquereliablemethodtodirectlyquan-
tify the ductal-to β-cell neogenesis. This is due to the com-
plexity of the mechanism, the involvement of many regulating
factors, and many cell intermediates, that are not universal but
may change according to the situation. The best way to esti-
matetheactivationofβ-cellneogenesisfromductsistoevaluate
concomitantlykeyparameterssuchas:proliferationrateofduc-
tal cells, number of isolated β-cells or β-cell clusters budding
from ducts [25], number of ductal cells co-expressing several
pancreatichormones[26],andﬁnallytheexpressionintheduct
cells of transcription factors involved in the differentiation of
β-cells.
Ductal Cell Precursors
The characterization of the ductal precursors has become
oneofthemajorchallengesfortheupcomingresearchinβ-cell
differentiation.Thephenotypeoftheseprecursorsisdifﬁcultto
identify and it seems to be different between fetus and adult.
In the fetus, markers for these precursors are Glut-2, TrkA, and
vimentin when co-expressed with CK20 [27]. In the adult no
real marker for ductal cell precursors has been identiﬁed. In
fact a co-expression of CK20-Insulin or CK20-Glucagon has
beendescribedinductalcells,howeverthesecellswerealready
in a late stage of differentiation, making this co-expression not
an early event of ductal-to β-cell neogenesis. In any case, the
adultcellprecursorandespeciallytheductalcellprecursorsare
verydifﬁculttoidentifyprobablybecauseoftheheterogeneous
cell population that expressed different markers at the different
stage of the β-cell differentiation [28].
Factors Regulating Neogenesis
from Duct Epithelium
A large number of factors controlling the differentiation of
β-cells has been identiﬁed. Currently, these factors are clas-
siﬁed in the following main categories: growth factors (i.e.,
TGFβ, TGFα, EGF, HGF, NGF, IGFs, and VEGF), regener-
ation factors (i.e., INGAP, Reg), cytokine and inﬂammatory
factors (i.e., TNFα, IL-6, INFγ), and other hormones such as
PTHrP and GLP-1. It is obviously impossible to recapitulate
all these factors and their possible actions. Therefore, we de-
cided to concentrate here on GLP-1 because of the increasing
interest for this factor as a stimulator of β-cell growth and its
potential use as a therapeutic agent in type 2 diabetes (detailed
information and references in Table 1).
GLP-1 and β-Cell Growth
GLP-1 is an intestinal incretin hormone derived from the
processingofproglucagon,thatexertsinsulinotropicactionson
insulin-producingpancreaticisletβ-cells(reviewedin29).The
importance of GLP-1 for stimulation of islet cell proliferation
wasoriginallydemonstratedinlean20-dayoldnormoglycemic
mice [30]. Afterwards, several studies using in vivo models
showedthatGLP-1canregulateisletgrowthmainlybycontrol-
ling β-cell neogenesis [31–35]. Our own observations, using a
recognized model of β-cells regeneration (neonatal Wistar rats
injected with streptozotocin, so-called n0-STZ), have shown
that GLP-1 and Exendin-4, applied during the neonatal period,
strongly stimulate β-cell regeneration mainly by β-cell neoge-
nesis [35]. Furthermore, treatment of diabetic Goto-Kakizaki
(GK) rats with GLP-1 or Exendin-4 from day 2 to day 6 after
birth, resulted in stimulation of β-cell neogenesis and prolifer-
ation with persistent expansion of β-cell mass detected at adult
age [34]. Altogether these suggest that GLP-1 and its analogs
exert a major trophic role on pancreatic β-cells, in addition to
theirs well-known effects on insulin biosynthesis and release.
The use of GLP-1 analogs gives for the ﬁrst time the possi-
bility to pharmacologically stimulate β-cells neogenesis from
precursor cells, even in diabetic adults.
GLP-1 and β-Cell Differentiation from Cell Lines
Several studies have shown that incubation of pancre-
atic exocrine cell lines with GLP-1 or Exendin-4 promotes
differentiation of these cells to an endocrine phenotype. AR42J
cells (rat pancreatic acinar cell line) treatment with GLP-1 or114 M. PARIS ET AL.
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FIGURE 2
(A) Hypothesis 1. Existence of a ductal cell precursor, which is able to proliferate and to differentiate into β-cell. (B)
Hypothesis 2. Quiescent ductal cells are able to prolif´ eration and differentiate into β-cells under the action of several different
factors (adapted from reference 23).PANCREATIC β-CELL 115
TABLE 1
Trophic role of GLP-1 and analogs on pancreatic β-cells. Main animal models and references
Animal models used Actions of GLP-1 or analogs References
Umea ob/+ or +/+ Increase of the pancreatic islet
growth
Edvell et al., 1999
Partially pancreatectomized rat (90% Px rats) Stimulation of β-cell replication
and neogenesis
Xu et al., 1999
db/db mouse, GLP-1 receptor null mouse Stimulation of PDX-1 expression
while stimulating neogenesis
Stoffers et al., 2000
Aging Wistar rats Increased of pancreatic β-cell mass
by stimulating β-cell
differentiation just at the back of
β-cell
Perfetti et al., 2000
Neonatal Wistar rat injected with
streptozotocin (n0-STZ)
Short- and long-term beneﬁcial
effects on β-cell mass recovery
Tourrel et al., 2001
Goto-Kakizaki rat (GK rat) Delay of the onset of type 2 diabetes
by expansion of β-cell mass
Tourrel et al., 2002
Exendin-4inducestheirdifferentiationintoislet-likecells.Dif-
ferentiated cells exhibit increased expression of β-cell genes
and the capacity to release insulin [36]. Similar experiments
werecarriedoutusingtwopancreaticductalcelllines,ratARIP
and human PANC-1 cells [37]. Interestingly, the differentia-
tion of PANC-1 cells which are PDX-1 negative into pancre-
atic β-like cells after GLP-1 or Exendin-4 treatment required
transfection with human IDX-1 (PDX-1), whereas ARIP cells,
which are naturally PDX-1 positive, spontaneously differenti-
ated into insulin-secreting cells after GLP-1 exposure. Finally,
in Capan-1 cells derived from human pancreatic ductal carci-
noma, exposed to Exendin-4 during several days, the number
of cells containing insulin and glucagon increased to 10% from
40% in the basal state [38].
GLP-1 and β-Cell Differentiation from Fetal and Adult
Islet Precursors
Several studies used fetal islet cell precursors to examine
whether exposure to GLP-1 or analogs is associated with en-
hanced differentiation of previously immature islet precursors.
Thus,Exendin-4hasbeenshowntoenhancePDX-1expression
inhumanislet-likecellclusterstreatedfor4daysinvitro.After
transplantationofthesecellclustersunderthekidneycapsuleof
athymic rats, a 10-day treatment with exendin-4 induced func-
tional maturation of transplanted cells and growth of clusters,
as assessed 8 weeks following the transplant [39]. Other exper-
imentsshowedthatthetreatmentwithGLP-1caninducediffer-
entiationandmaturationoffetalpigisletclustersduringculture.
Furthermore, transplantation of these in vitro treated cells into
immunodeﬁcient mice revealed an enhanced insulin secretion
when exposed to glucose in vivo [40]. Recently, Abraham et al.
reportedtheexpressionoffunctionalGLP-1receptorintonestin
positive islet-derived progenitor cells (NIPs) and that GLP-1
stimulatethedifferentiationofNIPsintoinsulin-producingcells
[41].
In summary, a large amount of evidence suggest that ad-
ministration of GLP-1 or agonist promotes differentiation of
functional of β-cells in vitro and vivo, thus strengthening the
possibilitythatGLP-1andanalogsmaybeusefulforproduction
of new β-cells and has important implications for the treatment
of type 1 and type 2 diabetes.
TRANSDIFFERENTIATION
Deﬁnition
Transdifferentiation (Figure 3) was ﬁrst deﬁned as the trans-
forming process from a worm stage into an insect. Now the
use of this termination has been enlarged, and applied for lot of
organsindifferentspecies.Oneofthebestexamplesisthetrans-
differentiation from retinal cell epithelium into neuron in the
chicken[42].Therelevanceofthisprocessforthegenerationof
newβ-cellsremainssomewhatcontroversialbutrecentstudies,
that will be reported below, support this concept. According to
these studies, the cells which can potentially “transdifferenti-
ate” into β-cells can belong to the pancreas, and even the islet,
itselfororiginatefromextra-pancreatictissuessuchastheliver.
Intra-Pancreatic Transdifferentiation
Endocrine Cells into Duct Cells
Using a tri-dimensional cell culture system, Yuan et al. have
observedthatisolatedisletfrompostmortempatientswereable
to transdifferentiate into ductal cells [43]. These ductal cells116 M. PARIS ET AL.
FIGURE 3
Schematic representation of the different possibilites of intra and extra pancreatic transdifferentiation in vivo.
presentedparticularpropertiessincetheystillexpressedenolase
whichisamarkeroftheendocrinetissue.Moreovertheauthors
observedtheappearanceoftheCK19amarkerofthefetalductal
cell, suggesting that these cells were not fully mature but rather
corresponded to cells expressing an intermediate phenotype.
Endocrine Cells into Acinar Cells
Using the pancreatic duct ligation model, Bertilli et al. have
shown by electron microscopy and dual immunostaining the
presence of cells co-expressing insulin and amylase in both en-
docrine and exocrine compartments [25]. Same results werePANCREATIC β-CELL 117
observed in transgenic mice overexpressing INFγ [44]. The
presenceofcellsdisplayingbothexocrineandendocrinemark-
ers emphasizes the existence of an intermediate step during the
transdifferentiationprocessasfoundinexperimentalmodelsof
pancreas remodeling that are associated with a strong β-cell
neogenesisactivity(reviewedin3).Finally,humanisletsmain-
tained in vitro for a period of one year, could transdifferentiate
in some particular conditions. Endocrine cells can transdiffer-
entiate into exocrine cells and subsequently into an undiffer-
entiated phenotype characterized by the expression of enolase,
vimentin, CK7 and CK19, TGFα and EGFR. These undiffer-
entiated cells are considered by the authors as precursor cells
[45].
Acinar Cells into Duct Cells
Studies on the transdifferentiation of acinar cells into duct
cells were initially performed essentially for the understanding
of the earliest events that happened during the cancer of the
pancreas. The study of 7 pancreases from patients suffering
from chronic pancreatisis showed a cell transformation from
an acinar phenotype into a ductal phenotype, as assessed by the
reductionofthenumberofzymogenegranulesandtheincrease
of the size of the lumen of the future duct [46]. Similarly, data
from in vitro studies found that human adult acinar cells could
transdifferentiate into ductal cells when cultured on a collagen
matrix [47]. Same results were observed by Hall et al. using
culturedhumanacinarcells[48],whileAriasetal.describedthe
same phenomenon using other species such as rats and guinea
pigs [49].
The AR42J Cell Model
AR42J is a cell line displaying acinar characteristics. These
cells are well known for their capacity to transdifferentiate into
different cell types when cultured in appropriate environment.
In the presence of activin A alone, they can turn into endocrine
phenotypeexpressingthepancreaticpolypeptide,whileinpres-
ence of activin A and β-cellulin, AR42J cells transdifferenti-
ate into insulin secreting cells [50]. Finally, in the presence of
GLP-1, AR42J cells can turn into insulin and glucagon produc-
ing cells [36].
Hepatocyte/Pancreas Transdifferentiation
During embryonic development cells that have the ability
to transdifferentiate generally come from adjacent region. The
transdifferentiation from hepatic cells to pancreas cells is prob-
ably one of the best documented [51] (Figure 3).
In 1986 Rao et al. observed the presence of pancreatic-
like tissue in the liver of rats when treated by polychlorinated
biphenyls, a carcinogenic agent. These cells organized in acini
asshownbylocationofthenucleusatthebasalpoleofthecells
and the presence of zymogen granules expressing amylase and
trypsinogen [52]. More recently, expression of pancreatic en-
zymes(α-amylase,trypsinogenandlipase)wasidentiﬁedinhu-
man liver during both development and maturation processes.
Using transgenic mice overexpressing INFγ and treated with
KGF, Krakowski et al. observed the appearance of hepatocytes
and duct cells in pancreatic islets. Interestingly, these insular
duct cells displayed a high proliferative activity [53].
Hepatocyte Cell Precursors into Pancreatic Cells
Some cells of the liver Hering duct have the ability to pro-
liferate and to regenerate upon hepatic lesion. These cells also
called oval cells express some epithelial markers as CK19 and
hepatic markers as albumin. Moreover, these cells are char-
acterized by the expression on their plasma membranes of
antigen such as, c-kitR and Thy-1, which are also express in
hematopo¨ ıetic stem cells. These oval cells are able to differ-
entiate in vitro into epithelial biliary duct cells and into hep-
atocytes. They are not considered as early cell precursors but
more likely as cell precursors dependent on regenerative pro-
cesses [51]. The most important characteristic of these oval
cells is that they are also found in pancreas in response to
speciﬁc stimuli. For example, in all models of transdifferen-
tiation from liver into pancreas, oval cells are found in pan-
creas and more precisely in the ductal tree or adjacent to it [52,
54–56].
Recently,Yangetal.showedthathepaticovalcellsinculture
could differentiate into insulin secreting cells with most of the
characteristics of mature β-cells. These cells could reverse dia-
beteswheninjectedintoadiabeticrat[57,58].Moreover,using
an approach based on ﬂow cytometry Suzuki et al. were able to
isolatehepaticstemcellsthatretainthecapacitytodifferentiate
into pancreatic cells [59].
INTRA-ISLET PRECURSORS
Tsanadis et al. have shown inside human fetal pancreatic
isletsthepresenceofacelltypemorphologicallydifferentfrom
the commonly described endocrine and exocrine cell types [4].
These cells look as hepatocyte-like cells descending from the
ductal cell precursors observed in rat and hamster. The authors
conclude that these cells were a new population of cell precur-
sors inside human fetal islets. Fernandes et al. have described
using two animal models, (streptozotocin-injected and NOD
mice), the presence of intra-islets cell precursors. These pre-
cursors co-expressing somatostatin and PDX-1 are able to dif-
ferentiate into β-cells when the pancreas has undergone a le-
sion [60]. Recently Guz et al. have described two potential cell
precursors located inside islets using a model of pancreatic re-
generation[61].Theﬁrstprecursor-typecouldexpressGLUT-2
as previously described by Pang et al. [62], while the second118 M. PARIS ET AL.
couldco-expresssomatostatinandinsulin.Takentogetherthese
studies strongly suggest the possibility of an activation of neo-
genesis directly from precursor cells located inside islets. This
processcouldbeconsideredastransdifferentiationofendocrine
non β-cells into β-cells.
Since a few years special attention was paid to intra-islet
nestinpositivecellsandforsomeauthorsnestinwasconsidered
as a potential marker of precursor cells within the islet. Nestin
is an intermediate ﬁlament protein identiﬁed as a marker for
a multipotent stem cell population in the central nervous sys-
tem [63]. Furthermore, nestin-expressing cells were reported
in pancreatic islets of adult mice [64], rats, and humans [65].
Clonigenicity and multipotency, including the capacity to form
newisletcells,werereportedfornestin-positivecellsfromadult
[65]andfetal[66]pancreas.Knowingtheroleofnestin-positive
cells in central nervous system, nestin appeared as the “ideal”
pancreaticprecursorcellsmarker.However,nestinhasalsobeen
described as a marker for reactive stellate cells, or pericytes,
andendothelialcellsduringactiveangiogenesis[67].Otherau-
thors reported that nestin is expressed in mesenchymal but not
epithelialcellprecursorsduringdevelopmentandisthusnotdi-
rectly involved in islet neogenesis [68, 69]. Therefore the role
of nestin-positive cells as endocrine pancreatic precursors re-
mainsverycontroversialandthemostrecentdatacastdoubtsas
to whether intra-islet nestin positive cells could be considered
as precursor cells in β-cell neogenesis [70–72]. However, the
role of nestin positive cells in β-cell neogenesis cannot be to-
tally excluded. Indeed, on the basis of an increasing amount of
studies [67, 71, 73], it can be proposed that nestin positive cells
indirectly may contribute to the generation of new endocrine
cells by promoting angiogenesis which in turn will promote
neogenesis by secreting trophic factors.
In conclusion, although different observations suggest the
presence of subpopulations of cell precursors inside islets of
Langerhans, it has been impossible so far to isolate precursor
cells from endocrine or ductal origins and the existence of such
cells must be considered with caution.
CONCLUSION
It has been long recognized that during late fetal and early
neonatal life, neogenesis is the main process which insures β-
cellgrowth.Thereisnowincreasingevidencethattheneogenic
process is also largely involved in β-cell mass homeostasis in
the adult. Moreover, neogenesis appears as crucial for pancreas
plasticity, which is a unique property of the endocrine pancreas
to adapt the β-cell mass to increased secretory demand without
hyperglycemia. This has been demonstrated repeatedly under
physiological (e.g., pregnancy, obesity) and pathological (e.g.,
growth hormone and cortisol excess) conditions [9]. In experi-
mentalmodelsofincreasedinsulindemand(prolongedglucose
infusion) neogenesis is even the only process allowing β-cell
growth [19, 20].
Theclassicaldeﬁnitionofendocrinecellneogenesisinvolves
theemergenceofendocrinecellsfromundifferentiatedprogen-
itor cells located in pancreatic ducts, which migrate into the
exocrine pancreas and proliferate to form the islets of Langer-
hans. We attempted here to review some of the recent studies
invivoandinvitrowhichpromptustothinkthatthegeneration
of new β-cells may be not restricted to this process and rather
be the result of different mechanisms and require different pan-
creatic and extra-pancreatic precursor cells. If pancreatic ducts
are the main source of precursor cells, it is unlikely that there
is a unique precursor and, for the moment, a speciﬁc marker
of these precursor cells is still lacking. The possible ability of
PDX-1 to induce insulin gene expression in pancreatic ducts
by a paracrine effect is a very interesting hypothesis, which
deserves further studies.
Ifthesearchofintra-isletprecursorsissomewhatdisappoint-
ingforthemoment,thepossibilityofanactivationofneogenesis
directlyfromprecursorcellslocatedinsideisletsissupportedby
some studies [60–62]. Especially, the conversion of endocrine
non β-cells into β-cells [61; Paris et al., personal communica-
tion] is a new way to explore. In addition, although nestin posi-
tive cells are very probably not intra-islet precursors of β-cells,
the studies on these cells opened a new research ﬁeld, i.e., the
relationship between β-cell neogenesis and angiogenesis [71].
Finally, to take advantage of the transdifferentiation pro-
cess, especially the transdifferentiation from acinar cells, as a
mechanismtoobtainasourceofdifferentiatedβ-cellsmaybea
direction for future cellular therapies. Acinar tissue in pancreas
represents more than 95% of the mass of the organ and may be
considered as a potential source of β-cell.
Ultimately, a better understanding of the molecular mecha-
nismsinvolvedinβ-cellneogenesiswillallowustouseanytype
of differentiated [74] and/or undifferentiated cells as a source
of potential cell precursors.
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